While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2025 financial and ...

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...

Bristol Myers Squibb (BMY) ended the recent trading session at $48.02, demonstrating a +2.85% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a ...

Our warm weather season is short, and it's important to enjoy the outdoors. The point isn't to be sun-scared — just stay ...

Analysts questioned whether the complete response letter Replimune received was evidence of changing approval standards at ...

Jim Cramer, a stalwart of stock market commentary, recently shifted gears on Bristol-Myers Squibb, pegging his hopes on their ...

The Cancer Immunotherapy market, valued at USD 220.94 billion in 2024, is expected to register robust revenue CAGR of 13.6%.

An oral neutrophil modulator appeared safe and demonstrated signals of efficacy in patients with moderate to severe ...

Explore the comprehensive Pulmonary Arterial Hypertension (PAH) market forecast, covering 68 global markets. From $10.1 billion in 2024 to $17.9 billion by 2034, the 7 major markets lead with 48% ...

The Global Bladder Cancer Market was valued at USD 4.4 Billion in 2024, and it is expected to reach USD 7.2 Billion by 2035, ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...